![Feng Ming Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Ming Liu
Director Ejecutivo en Changzhou Biowin Pharmaceutical Co., Ltd. .
Perfil
Feng Ming Liu is currently the Chairman & General Manager at Changzhou Biowin Pharmaceutical Co., Ltd.
Previously, he worked as the Chief Executive Officer & Chief Scientist at Shineco, Inc. Liu holds a doctorate degree from Peking Union Medical College.
Cargos activos de Feng Ming Liu
Empresas | Cargo | Inicio |
---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Director Ejecutivo | 01/01/2012 |
Antiguos cargos conocidos de Feng Ming Liu.
Empresas | Cargo | Fin |
---|---|---|
SHINECO, INC. | Director Ejecutivo | - |
Formación de Feng Ming Liu.
Peking Union Medical College | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SHINECO, INC. | Process Industries |
Empresas privadas | 1 |
---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Feng Ming Liu